Table 3.
Brachytherapy dose volume histogram target for the high risk clinical target volume (CTVHR), rectum and bladder adapted from ESGO/ESTRO quality indicators for radiation therapy of cervical cancer, Chargari et al (2023) [13].
| Target Dose |
D90CTVHR EQD210 |
D98CTVHR EQD210 |
D98GTVres EQD210 |
D98CTVIR EQD210 |
||
|---|---|---|---|---|---|---|
| Minimum dose constraint (optimal constraints) | >85 Gy (>90 and < 95 Gy) |
>75 Gy (>80 Gy) |
>90 Gy (>95 Gy) |
>60 Gy (−) |
||
| OARs |
Rectum D2cm3 EQD23 |
Bladder D2cm3 EQD23 |
ICRU rectovaginal point D2cm3 EQD23 |
ICRU bladder point D2cm3 EQD23 |
Bowel D2cm3 EQD23 |
Sigmoid D2cm3 EQD23 |
| Maximum dose constraint (optimal constraints) | <75 Gy (<65 Gy) |
<85 Gy (<80 Gy) |
<75 Gy (<65 Gy) |
<85 Gy (<75 Gy) |
<75 Gy (<65 Gy) |
<75 Gy (<70 Gy) |